Xuan B. Wan
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT).
Journal: Molecules (Basel, Switzerland)
Published: March 14, 2026
The chitosan collagen salvianolic membrane mitigates intervertebral disc degeneration through suppression of the Wnt/β-catenin signaling.
Journal: In vitro cellular & developmental biology. Animal
Published: November 20, 2025
Research progress in mechanisms of kidney-tonifying traditional Chinese medicine in promoting healing of osteoporotic fractures
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: October 14, 2025
Determinants of health poverty vulnerability of rural households in Jiangxi Province, China: an analysis based on risk theory.
Journal: BMC public health
Published: July 10, 2025
Finite element analysis of short-segment fixation combined with expandable polyetheretherketone vertebral body replacement in osteoporotic vertebrae.
Journal: BMC musculoskeletal disorders
Published: April 16, 2025
Qi-Gu capsule alleviates osteoporosis by inhibiting mesenchymal stem cell senescence via the HIF-1α/AMPK axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 06, 2025
Structure-Based Drug Design of 2-Amino-[1,1'-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer.
Journal: Journal of medicinal chemistry
Published: August 20, 2024
Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cascade.
Journal: Pulmonary pharmacology & therapeutics
Published: September 28, 2023
Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis.
Journal: Frontiers in pharmacology
Published: September 18, 2023
GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells.
Journal: OncoTargets and therapy
Published: August 10, 2023
Last Updated: 09/26/2026